| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/11/2004 | WO2003034978A3 Antidiabetic 2-substituted-5'-o- (1-boranotriphosphate) adenosine derivatives |
| 03/11/2004 | WO2003026479A3 Methods of suppressing microglial activation |
| 03/11/2004 | WO2003020213A3 Methods and compositions for treating inflammatory disorders |
| 03/11/2004 | WO2003018799A3 Modulators of bone homeostasis identified in a high-throughput screen |
| 03/11/2004 | WO2003009809A3 Cancer treatment with gö6976 and its related compounds |
| 03/11/2004 | WO2003000695A8 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/11/2004 | WO2003000191A3 Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints |
| 03/11/2004 | WO2003000185A3 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/11/2004 | WO2002099050A3 Tprs as modifiers of the p53 pathway and methods of use |
| 03/11/2004 | WO2002096349A3 Vaccination against the feline immunodeficiency virus |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002076404A3 Fatty alcohol drug conjugates |
| 03/11/2004 | US20040049799 Method for screening agents capable of treating obesity |
| 03/11/2004 | US20040049083 Arylpiperazines having activity at the serotonin 1A receptor |
| 03/11/2004 | US20040049072 RXR modulators with improved pharmacologic profile |
| 03/11/2004 | US20040049046 Small molecule inhibitors of rotamase enzyme activity |
| 03/11/2004 | US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease |
| 03/11/2004 | US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/11/2004 | US20040049032 Inhibitors of protein kinases, especially Aurora kinase; anticancer agents |
| 03/11/2004 | US20040049023 Useful in the study of vascular smooth muscle cell proliferation and in the treatment of blood vessel diseases that result from excessive smooth muscle cell proliferation, particularly after balloon angioplasty |
| 03/11/2004 | US20040049017 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring |
| 03/11/2004 | US20040049016 The glycoproteins induce apoptosis and can be used as a therapeutic agent against Flavivirus infection and cancer |
| 03/11/2004 | US20040048920 2-(p-(1-hydrocarbylsulfonylalkyl)phenyl)-1,1,1,3,3,3-hexafluoro-2-propanol derivatives; treating atherosclerosis, dyslipidemia, diabetes, Alzheimers disease, and Niemann-Pick disease. |
| 03/11/2004 | US20040048912 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/11/2004 | US20040048909 N-alkyl-N-(p-substituted-phenyl)benzylamine that is N-substituted with carbocyclic aminocarbonylalkylene, aminocarbonyl, or aminocarbonylaminosulfonyl; ACAT inhibitors; treating e.g.,hypercholesterolemia and atherosclerosis |
| 03/11/2004 | US20040048907 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/11/2004 | US20040048906 Synergistic combinations of amlodipine and atorvastatin used to treat angina pectoris, atherosclerosis, combined hypertension and hyperlipidemia and to treat subjects with symptoms of cardiac risk |
| 03/11/2004 | US20040048902 Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient |
| 03/11/2004 | US20040048901 Increased water solubility and bioabsorption; treatment of CNS disorders such as depression and emesis |
| 03/11/2004 | US20040048897 Il-8 receptor antagonists |
| 03/11/2004 | US20040048892 Treatment of diseases with adamantane derivatives |
| 03/11/2004 | US20040048891 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 03/11/2004 | US20040048888 1,6-naphthyridineurea derivatives; treating excessive or undesirable angiogenesis and/or Tie2 receptor activity |
| 03/11/2004 | US20040048882 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 03/11/2004 | US20040048878 Heterocyclic compounds |
| 03/11/2004 | US20040048875 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 03/11/2004 | US20040048869 Dopamine D4 receptor antagonist with antidepressant or anxiolytic agent. |
| 03/11/2004 | US20040048867 Especially quinoline carbonyl pyrrolidines with binding selectivity to benzodiazepine site of GABAA receptor to treatanxiety, depression, a sleep disorder, or cognitive impairment. |
| 03/11/2004 | US20040048859 Substituted glutarimides and their use as inhibitors of IL-12 production |
| 03/11/2004 | US20040048858 Chalcone derivatives and their use to treat diseases |
| 03/11/2004 | US20040048855 Inhibitors of interleukin 1-beta converting enzyme |
| 03/11/2004 | US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/11/2004 | US20040048851 Amidinophenylalanine derivatives as thrombin inhibitors |
| 03/11/2004 | US20040048849 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors |
| 03/11/2004 | US20040048848 Novel gamma secretase inhibitors |
| 03/11/2004 | US20040048846 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications |
| 03/11/2004 | US20040048840 Modulation of matrix metalloproteinase (MMP) activity with aldosterone blocker(s) |
| 03/11/2004 | US20040048816 Restenosis treatment |
| 03/11/2004 | US20040048815 Low-molecular serine proteases inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals |
| 03/11/2004 | US20040048805 Antilipemic agents |
| 03/11/2004 | US20040048801 Use of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory:pre-and post-natal administration |
| 03/11/2004 | US20040048799 Combination therapy using a TNF binding protein for treating TNF-mediated diseases |
| 03/11/2004 | US20040048785 By fibroblasts and/or keratinocytes; particularly hyaluronic acid, and/or proteoglycans |
| 03/11/2004 | US20040048774 Inhibitors of IMPDH enzyme |
| 03/11/2004 | US20040048754 Capable of releasing perfumery, flavor, insect repellent or attractant, bactericide or fungicides |
| 03/11/2004 | US20040048372 Extracting and recovering embryonic-like stem cells, including pluripotent or multipotent stem cells, from an exsanguinated human placenta; use of the isolated and perfused placenta as a bioreactor in which to propagate endogenous/exogenous cells |
| 03/11/2004 | US20040048325 Glycosyltransferase inhibitors |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048280 A polynucleotide that includes an endothelial specific enhancer element |
| 03/11/2004 | US20040048266 Regulation of human membrane-type serine protease |
| 03/11/2004 | US20040047924 Anti proliferative preparations |
| 03/11/2004 | US20040047903 For use in therapy of cancer |
| 03/11/2004 | US20040047900 Treatment of posterior capsule opacification |
| 03/11/2004 | US20040047896 Composition for improving age-related physiological deficits and increasing longevity |
| 03/11/2004 | US20040047890 Containing the viable cells, or tissue comprising the viable cells, prior to transplantation within a device comprising a semipermeable membrane; treating subject with a substance which inhibits an immune-system costimulation |
| 03/11/2004 | US20040047863 Administering TNF(Tumor necrosis factor) binding protein and at least one additional anti-inflammatory drug, for therapy of an acute or chronic inflammatory disease |
| 03/11/2004 | US20040047860 Antibodies to human mcp-1 |
| 03/11/2004 | US20040047851 Treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingomyelinase inhibitors effective to decrease |
| 03/11/2004 | US20040047832 Cosmetic and/or dermopharmaceutical preparations containing leaf extracts of the plant argania spinosa |
| 03/11/2004 | US20040047824 Topical use containing at least one oxidation-sensitive hydrophilic active principle and at least one maleic anhydride copolymer, comprising one or more maleic anhydride comonomers and one or more comonomers selected from the group |
| 03/11/2004 | CA2706622A1 Lps activation of phagocytic activity |
| 03/11/2004 | CA2537158A1 Cxcr4 antagonist and use thereof |
| 03/11/2004 | CA2502734A1 Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient |
| 03/11/2004 | CA2496920A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | CA2496789A1 Methods for preserving organs and tissues |
| 03/11/2004 | CA2496695A1 New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2(1-piperazinyl)thieno{2,3-d}pyrimidine |
| 03/11/2004 | CA2496612A1 Embolization |
| 03/11/2004 | CA2496550A1 Composition based on triethyl citrate for the treatment of bacterial infections of the skin |
| 03/11/2004 | CA2496358A1 Hair growth stimulants for oral use |
| 03/11/2004 | CA2495437A1 Novel crystal |
| 03/11/2004 | CA2492645A1 Novel combination of glucocorticoids and pde-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and copd |
| 03/11/2004 | CA2488739A1 Nitrogen-containing aromatic derivatives |
| 03/10/2004 | EP1396545A1 Cell cycle regulatory factor |
| 03/10/2004 | EP1396542A2 Novel P-selectin ligand protein |
| 03/10/2004 | EP1396493A1 Heterocyclic compounds |
| 03/10/2004 | EP1396492A1 Prodrug of an ice inhibitor |
| 03/10/2004 | EP1396491A2 2-substituted 4,5-diaryl-imidazoles and their use as p38 MAP kinase inhibitors |
| 03/10/2004 | EP1396490A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives |
| 03/10/2004 | EP1396488A1 Fused heterocyclic compound and medicinal use thereof |
| 03/10/2004 | EP1396487A1 Phenylpyridine carbonyl piperazine derivative |
| 03/10/2004 | EP1396271A1 Use of germination-activated ganoderma lucidium spores as anti-aging agent and against menopause symptoms |
| 03/10/2004 | EP1396266A1 Aqueous cilostazol preparation for injection |
| 03/10/2004 | EP1395656A2 Human drug metabolizing enzymes |
| 03/10/2004 | EP1395611A2 Methods and compositions for treating respiratory mucin production associated disease conditions |
| 03/10/2004 | EP1395610A2 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same |
| 03/10/2004 | EP1395607A2 Respiratory syncytial virus |
| 03/10/2004 | EP1395606A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 03/10/2004 | EP1395605A2 Polymeric immunoglobulin fusion proteins that target low-affinity fcgamma receptors |
| 03/10/2004 | EP1395604A1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives |
| 03/10/2004 | EP1395602A2 Novel human potassium channel beta subunit |